TFFP - TFF Pharmaceuticals GAAP EPS of -$1.25 misses by $0.12 revenue of $0.09M misses by $0.59M
TFF Pharmaceuticals press release (NASDAQ:TFFP): FY GAAP EPS of -$1.25 misses by $0.12. Revenue of $0.09M misses by $0.59M. As of December 31, 2021, TFF Pharmaceuticals reported cash and cash equivalents of $33.8 million. Shares +0.15%.
For further details see:
TFF Pharmaceuticals GAAP EPS of -$1.25 misses by $0.12, revenue of $0.09M misses by $0.59M